The U.S. Food and Drug Administration (FDA) has approved the use of CSL Limited’s 2009 H1N1 influenza vaccine to include children ages 6 months and older. The vaccine was previously approved only for use in adults, ages 18 years and older. The expanded approval also covers the Australian company’s seasonal flu vaccine.

The vaccines will be available in single-dose, preservative-free, pre-filled syringes, and multi-dose vials.

Add a Comment

Name (required)

Email Address (will not be published) (required)

Attention: AAPC does not regularly monitor comments posted here. For customer service issues, contact us. In addition, we recommend posting your questions to the AAPC forums.

CAPTCHA Code *